"Dyslipidemias" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Abnormalities in the serum levels of LIPIDS, including overproduction or deficiency. Abnormal serum lipid profiles may include high total CHOLESTEROL, high TRIGLYCERIDES, low HIGH DENSITY LIPOPROTEIN CHOLESTEROL, and elevated LOW DENSITY LIPOPROTEIN CHOLESTEROL.
| Descriptor ID |
D050171
|
| MeSH Number(s) |
C18.452.584.500
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Dyslipidemias".
Below are MeSH descriptors whose meaning is more specific than "Dyslipidemias".
This graph shows the total number of publications written about "Dyslipidemias" by people in this website by year, and whether "Dyslipidemias" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2005 | 2 | 3 | 5 |
| 2006 | 7 | 0 | 7 |
| 2007 | 2 | 2 | 4 |
| 2008 | 6 | 1 | 7 |
| 2009 | 4 | 2 | 6 |
| 2010 | 5 | 2 | 7 |
| 2011 | 9 | 3 | 12 |
| 2012 | 8 | 0 | 8 |
| 2013 | 8 | 2 | 10 |
| 2014 | 5 | 1 | 6 |
| 2015 | 7 | 6 | 13 |
| 2016 | 7 | 4 | 11 |
| 2017 | 4 | 2 | 6 |
| 2018 | 12 | 2 | 14 |
| 2019 | 16 | 0 | 16 |
| 2020 | 9 | 2 | 11 |
| 2021 | 6 | 4 | 10 |
| 2022 | 5 | 0 | 5 |
| 2023 | 4 | 0 | 4 |
| 2024 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Dyslipidemias" by people in Profiles.
-
Prevalence of Cardiometabolic Risk Factors in Women: Insights From the Houston HeartReach Study. Tex Heart Inst J. 2024 Sep 27; 51(2).
-
The association between dyslipidaemia in the first trimester and adverse pregnancy outcomes in pregnant women with subclinical hypothyroidism: a cohort study. Lipids Health Dis. 2024 Jan 11; 23(1):13.
-
Stunted Growth Is Associated With Dyslipidemia in Young Adults With Perinatal HIV Infection. J Acquir Immune Defic Syndr. 2023 08 01; 93(4):343-350.
-
Algorithms for Treating Dyslipidemia in Youth. Curr Atheroscler Rep. 2023 08; 25(8):495-507.
-
Double-Trouble: Atherosclerotic Risk Factors and Congenital Heart Disease. Curr Atheroscler Rep. 2023 07; 25(7):417-426.
-
Update on management of paediatric dyslipidaemia. Curr Opin Endocrinol Diabetes Obes. 2023 02 01; 30(1):52-64.
-
Clustering Patients With Gout Based on Comorbidities and Biomarkers: A Cross-Sectional Study. J Rheumatol. 2023 06; 50(6):817-826.
-
A stepwise approach to prescribing novel lipid-lowering medications. J Clin Lipidol. 2022 Nov-Dec; 16(6):822-832.
-
World Heart Federation Cholesterol Roadmap 2022. Glob Heart. 2022; 17(1):75.
-
Use of lipid-lowering therapies in patients with chronic kidney disease and atherosclerotic cardiovascular disease: 2-year results from Getting to an imprOved Understanding of Low-Density lipoprotein cholesterol and dyslipidemia management (GOULD). Clin Cardiol. 2022 Dec; 45(12):1303-1310.